Anti cancer Tablets

Product Details:

IRESSA Tablet

Iressa is a professionally prescribed medicine used to treat non-little cell lung malignant growth. Iressa has a place with a gathering of medications called epidermal development factor receptor (EGFR) tyrosine kinase inhibitors. It is thought to work by obstructing the activity of a specific normally happening substance that might be expected to help malignant growth cells develop and increase.

Uses of IRESSA Tablet

Iressa Tablet is utilized in the treatment of non-little cell lung malignancy. It is utilized in patients in which it has spread to different parts of the body, who have unusual epidermal development factor receptor (EGFR) qualities, and who have not had past treatment for malignant growth.

What side-effects are possible with this prescription?

Contact your specialist if you encounter these reactions and they are serious or annoying. Your drug specialist might have the capacity to prompt you on overseeing reactions.

• Sickness

• Rash  

• weakness

• Loss of hunger

• Vomiting

• Dry skin

• Loose Bowels

• Stomatitis (Inflammation of the mouth)

How to take IRESSA tablet?

Continuously take this medication precisely as your specialist has advised you know. Check with your specialist or drug specialist if you are not sure.

• The suggested dose is one tablet for each day.

• Take the tablet at about a similar time every day.

• You can take the tablet with or without a meal.

Try not to take antacids (to decrease the acid level of your stomach) 2 hours prior or 1 hour after taking IRESSA.

Product Details:

Jakavi tablet

Jakavi 5Mg Tablet is a kind of kinase inhibitor used to treat bone marrow issues like myelofibrosis and polycythemia Vera if there is a lacking reaction or narrow mindedness towards hydroxyurea. Its component includes blocking substances associated with myelofibrosis, as JAK1 and JAK2.

Uses of Jakavi tablet

This prescription is utilized in sickness-related splenomegaly (spleen augmented strangely) or manifestations in essential myelofibrosis (bone marrow issue) or in myelofibrosis because of Polycythemia Vera (a sort of blood malignant growth) or fundamental thrombocythemia (expanded platelets because of blood issue).

Side-effects of Jakavi 5Mg Tablet

Patients taking this medication may understand urinary tract contamination, herpes zoster, iron deficiency, thrombocytopenia (low platelet check), neutropenia (low white platelets), dying, weight gain, hypercholesterolemia (raised cholesterol), tipsiness, cerebral pain, or flatulence (gas in the stomach). In the event that you experience any of these manifestations please counsel your specialist.

How to utilize Jakavi 5Mg Tablet?

The prescribed beginning dose of Jakavi relies upon the condition being dealt with and a baseline level of certain platelets (e.g., platelets, hemoglobin, neutrophils). Your specialist will change your dose depending on how you react to and endure this drug.

This prescription can be taken with or without a meal. Gulp down the tablets with a glass of water. Try not to break, chew, or bite the tablets. It is important to take this medicine around a similar time each day.

How does JAKAVI Tablet work?

Jakavi Tablet is utilized in the treatment of myelofibrosis, a sort of bone marrow issue. This medication, being a Janus kinase inhibitor, prevents disarticulated JAK signaling that may result in myelofibrosis.

Professional Advice

• You will be suggested to visit blood tests (each 2 to about a month) and your specialist can change the dose-dependent on your test reports.

• Tell your specialist if you have or have had any diseases, for example, tuberculosis (TB), hepatitis and so forth or any disarranges of the kidney, liver or any type of skin malignant growths.

• Try not to take Jakavi before a dialysis treatment.

• Take mandatory precautions as Jakavi may decrease the quantity of clot- framing cells (platelets) in your blood and the capacity of your body to battle disease.

• Look for quick medical care if you encounter unexplained bruising, sudden bleeding, uncommon tiredness, trouble in breathing, fair skin, frequent diseases, fever, chills, delayed coughing, expanded sweating during the evening, sudden weight reduction, loss of balance, challenges in strolling/coordination, talking challenges, awkwardness, trouble in considering, obscuring of vision, shortcoming on one side of body, difficult skin rashes with rankles or any strange skin changes.

• Try not to give Jakavi to youngsters matured underneath 18 years.

• Try not to drive or work hardware after utilizing Jakavi as it might cause trouble.

• Tell your specialist if you are or intend to become pregnant or breastfeeding.

• Try not to take if adversely affected by Jakavi or any of its ingredients.

Product Details:

Exemestane was approved by the U.S. FDA in October 2005. The drug is commercialized under the brand name Aromasin by Pfizer and is used as an adjuvant treatment in postmenopausal women who suffer from estrogen receptor positive early-stage breast cancer. Women generally begin taking exemestane after they’ve been on tamoxifen for two to three years, then switch to exemestane for two to three years, for a total of five consecutive years of adjuvant hormonal therapy.

The FDA’s approval of the drug was based on a double-blind, multi-center, international clinical trial that included 4,724 postmenopausal women with early-stage breast cancer, known as the Intergroup Exemestane Study (IES).

“After a median duration of randomized therapy of 27 months and with a median duration of follow-up of 34.5 months, DFS [disease-free survival] was significantly improved in patients who switched to exemestane compared to those who continued tamoxifen,” according to the NCI. “In the hormone receptor-positive subpopulation representing about 85 percent of the trial patients, DFS was significantly improved in the exemestane arm compared to the tamoxifen arm.”

The same study indicated that the most common side effects of the treatment include hot flashes, fatigue, joint pain, headache, insomnia, increased sweating, hypertension, and dizziness. Rarer adverse events, such as heart problems, can also occur.

Product Details:

Brand Name – Rapact Tablets

Marketed – Natco

Active Ingredient(s) – Everolimus

Strength – 5mg And 10mg
Dosage Form – Tablet
Package Size – 4X7 Tabs
Package Type – Bottle
Expiry – 1 Year to 2 Years
Indication(s) – used in breast cancer, pancreatic cancer, lung cancer and kidney cancer.

Prescription Required – Yes

Note: These Tablets is a prescription drug. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.
Minimum Order Quantity: 1 Piece(s)
Port of Dispatch: New Delhi, India
Production Capacity: As per your required

RAPACT Tablet is an immunosuppressant. It works by blocking the action of certain blood cells in the immune system that may cause the body to reject the transplanted organ.

RAPACT Tablets is used with other medications (such as cyclosporine) to prevent rejection of a kidney transplant. Everolimus is also used with other medications (such as tacrolimus) to prevent rejection of a liver transplant.

Constipation, headache, nausea, and sores in the mouth/throat may occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.

Tell your doctor right away if you have any serious side effects, including swelling hands/ankles/feet, wound problems (such as infection, slow wound healing,open wounds), decreased sexual ability (male), chest pain/stress shortness, Unusual bruising/bleeding.

Everolimus may cause your cholesterol/triglycerides or blood sugar to rise.

This is not a complete list of possible side effects. If you notice other effects not listed above, please contact your doctor or pharmacist.

Product Details: